Efficacy & Outcomes
No marketing fluff. Just the raw response and remission rates from major clinical trials and our own internal audits.
The STAR*D Reality
The largest study ever conducted on depression treatments (STAR*D) proved that medication efficacy plummets with every failed trial.
- Trial 1 Remission: 36.8%
- Trial 2 Remission: 30.6%
- Trial 3 Remission: 13.7%
- Trial 4 Remission: 13.0%
TMS Efficacy (Carpenter et al, 2012)
In a real-world, multi-site study of 307 patients who had already failed an average of 2.5 medications:
58.0%
Response Rate (Symptoms cut in half)
37.1%
Remission Rate (Virtually symptom-free)